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Abstract
CaV1/CaV2 channels, comprised of pore-forming a1 and auxiliary (b,a2d) subunits, control diverse biological responses in
excitable cells. Molecules blocking CaV1/CaV2 channel currents (ICa) profoundly regulate physiology and have many
therapeutic applications. Rad/Rem/Rem2/Gem GTPases (RGKs) strongly inhibit CaV1/CaV2 channels. Understanding how
RGKs block ICa is critical for insights into their physiological function, and may provide design principles for developing
novel CaV1/CaV2 channel inhibitors. The RGK binding sites within CaV1/CaV2 channel complexes responsible for ICa
inhibition are ambiguous, and it is unclear whether there are mechanistic differences among distinct RGKs. All RGKs bind b
subunits, but it is unknown if and how this interaction contributes to ICa inhibition. We investigated the role of RGK/b
interaction in Rem inhibition of recombinant CaV1.2 channels, using a mutated b (b2aTM) selectively lacking RGK binding.
Rem blocked b2aTM-reconstituted channels (74% inhibition) less potently than channels containing wild-type b2a (96%
inhibition), suggesting the prevalence of both b-binding-dependent and independent modes of inhibition. Two mechanistic
signatures of Rem inhibition of CaV1.2 channels (decreased channel surface density and open probability), but not a third
(reduced maximal gating charge), depended on Rem binding to b. We identified a novel Rem binding site in CaV1.2 a1C N-
terminus that mediated b-binding-independent inhibition. The CaV2.2 a1B subunit lacks the Rem binding site in the N-
terminus and displays a solely b-binding-dependent form of channel inhibition. Finally, we discovered an unexpected
functional dichotomy amongst distinct RGKs— while Rem and Rad use both b-binding-dependent and independent
mechanisms, Gem and Rem2 use only a b-binding-dependent method to inhibit CaV1.2 channels. The results provide new
mechanistic perspectives, and reveal unexpected variations in determinants, underlying inhibition of CaV1.2/CaV2.2
channels by distinct RGK GTPases.
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Introduction
Ca
2+ influx via high-voltage-activated CaV1/CaV2C a
2+ chan-
nels links electrical signals to physiological responses in excitable
cells, and consequently, regulates myriad biological functions
ranging from muscle contraction to hormone and neurotransmit-
ter release [1,2]. CaV1/CaV2 channel activity is modulated by
various intracellular signaling molecules, and this serves as a
powerful method to alter physiology [1,3]. Furthermore, molecules
that selectively inhibit CaV1/CaV2 channels are current or
prospective therapeutics for serious cardiovascular (e.g. hyperten-
sion, angina) and neurological (e.g. Parkinson’s disease, neuro-
pathic pain, stroke) diseases [4,5,6,7,8].
Rad/Rem/Rem2/Gem (RGK) proteins are a four-member
subfamily of the Ras superfamily of monomeric GTPases [9], and
are the most potent known intracellular inhibitors of CaV1/CaV2
channels [10,11,12]. RGK proteins are present in excitable
tissue— including skeletal/cardiac muscle, nerve, and endocrine
cells— suggesting that their inhibition of CaV1/CaV2 channels has
physiological significance. Consistent with this notion, suppression
of basal Rad expression in heart increases L-type CaV1.2 calcium
current (ICa,L) and leads to cardiac hypertrophy [13,14]. Mech-
anistically, RGK GTPases inhibit CaV1/CaV2 channels using
multiple methods [15]. For example, Rem inhibits recombinant
CaV1.2 channels reconstituted in HEK 293 cells using at least
three independent mechanisms [16]: (1) by decreasing the number
of channels (N) at the cell surface; (2) by inhibiting open probability
(Po) of surface channels; and (3) by partially immobilizing voltage
sensors as reported by a reduced maximal gating charge (Qmax).
A core unanswered question relates to the geographical
localization of RGK binding site(s) on CaV1/CaV2 channel
complexes responsible for ICa inhibition. Mature CaV1/CaV2
channels are macro-molecular complexes comprised minimally of
a pore-forming a1 protein assembled with auxiliary b/a2d
subunits, and calmodulin [2,17]. CaVb is required for a1
trafficking to the plasma membrane, enhancing channel open
probability (PO), and normalizing channel gating [18,19]. All four
RGKs bind CaVbs and it has been widely assumed, though not
proven, that the RGK/b interaction is essential for CaV1/CaV2
channel inhibition [10,12,15,20]. This notion has been strongly
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Gem inhibition of neuronal P/Q-type (CaV2.1) channels [21].
This new provocative result raises several outstanding fundamen-
tal questions. First, it is now unclear whether the RGK/b
interaction plays any role in ICa inhibition, or whether it is merely
an unrelated epi-phenomenon. Second, though it has been
proposed that RGKs may inhibit CaV1/CaV2 channels by
binding directly to pore-forming a1 subunits [21,22], to date no
RGK binding site responsible for ICa reduction has been described
for any a1-subunit isoform. Third, while it is formally possible that
distinct RGKs may use different mechanisms and determinants to
inhibit individual CaV1/CaV2 channels, this idea has not been
explored.
Here, we report that Rem uses both b-binding-dependent and
b-binding-independent mechanisms to inhibit recombinant
CaV1.2 channels. We identified a novel Rem binding region on
the N-terminus of the pore-forming CaV1.2 a1C subunit that
mediates b-binding-independent inhibition. The N-type (CaV2.2)
channel a1B subunit lacks the Rem binding site in the N-terminus
and displays only b-binding-dependent inhibition. Finally, we
discovered that distinct RGK GTPases differ in their use of the
two determinants for CaV1.2 channel suppression— Rem and
Rad use both b-binding-dependent and independent mechanisms,
whereas Gem and Rem2 solely utilize a b-binding-dependent
mode of inhibition.
Results
Rem inhibits CaV1.2 channels using both b-binding-
dependent and b-binding-independent mechanisms
Rem potently inhibits recombinant CaV1.2 channels (a1C/b2a)
reconstituted in HEK 293 cells (Fig. 1 B and C). Cells transiently
transfected with a1C+b2a generate robust ICa,L which is virtually
eliminated (96% inhibition) when Rem is co-expressed (Fig. 1 B
and C). It is unknown whether this dramatic effect is mediated
through Rem binding to the auxiliary b, the pore-forming a1C
subunit, or both (Fig. 1A). To address this issue, we introduced
three point mutations (D243A, D319A and D321A) into b2a to
generate a mutant (b2aTM) that selectively loses binding to RGK
proteins, as previously demonstrated [23] and confirmed here (Fig.
S1). Cells expressing mutant CaV1.2 channels reconstituted with
a1C+b2aTM yielded strong ICa,L with amplitude and voltage-
dependence indistinguishable from wild-type CaV1.2 (Fig. 1 D and
E), demonstrating that the mutations did not adversely affect the
structure and functional interaction of b with a1C. Rem inhibited
ICa,L through mutant a1C+b2aTM CaV1.2 channels (Fig. 1 D and
E). However, the magnitude of Rem inhibition of mutant channels
(74%) was significantly less than observed with wild type CaV1.2
(Fig. 1). The intermediate impact of Rem on a1C+b2aTM channels
indicates Rem inhibits CaV1.2 channels using both b-binding-
dependent and independent mechanisms.
We previously reported that Rem inhibits CaV1.2 channels
using multiple, independent methods: decreasing N, Po, and Qmax
[16]. We investigated which, if any, of these distinct mechanisms is
dependent on Rem binding to b. To quantitatively determine the
relative CaV1.2 surface density we introduced a 13-residue high-
affinity bungarotoxin (BTX) binding site (BBS) into the extracel-
lular domain II S5–S6 loop in a1C-YFP [16]. Surface a1C[BBS]-
YFP was detected in non-permeabilized cells by sequential
exposure to biotinylated BTX and streptavidin-conjugated quan-
tum dot (QD). Labeled cells are then subject to flow cytometry,
permitting high throughput measurements of fluorescence signals
[16,24] (Fig. S2). Cells expressing a1C[BBS]-YFP+b2a displayed a
strong QD655 fluorescence signal (Fig. 2A, top row), indicating an
abundance of channels at the cell surface. Co-expression of CFP-
Rem with wild-type CaV1.2 markedly decreased N, as reported by
a ,75% decrease in mean QD655 fluorescence (Fig. 2A;
normalized mean QD655 fluorescence=0.2660.01, n=3 inde-
pendent flow cytometry experiments in cells co-expressing CFP-
Rem compared to control cells expressing a1C[BBS]-YFP+b2a
alone). These results are consistent with our previous observations
[16]. Cells expressing a1C[BBS]-YFP+b2aTM displayed a similar
channel surface density as control a1C[BBS]-YFP+b2a cells
(Fig. 2B; normalized mean QD655 fluorescence=0.9460.04,
n=3). Interestingly, CFP-Rem barely decreased QD655 fluores-
cence in cells expressing a1C[BBS]-YFP+b2aTM (Fig. 2B; normal-
ized mean QD655 fluorescence=0.7760.02, n=3), compared to
the substantial drop observed with control channels (Fig. 2A).
Therefore, the ability of Rem to reduce N is critically dependent
on its capacity to bind b.
A second mode of Rem inhibition of CaV1.2 involves a
reduction in channel Po that depends on membrane targeting of
Rem’s nucleotide binding domain (NBD) [16,20]. When expressed
in cells, wild-type Rem autonomously targets to the inner leaflet of
the plasma membrane via electrostatic and hydrophobic interac-
tions afforded by basic and aromatic residues in the distal C-
terminus [25]. A Rem truncation mutant, Rem265, featuring a
deletion of the final 32 amino acid residues in the C-terminus,
loses both membrane targeting and the ability to block ICa
[12,16,20]. Replacing the deleted 32 residues with a generic
membrane-targeting domain rescues the capacity to inhibit ICa
[26]. We exploited this feature to generate an inducible CaV
channel inhibitor by placing the C1 domain of protein kinase Cc
(PKCc) to the end of CFP-Rem265 [16]. When expressed in cells,
the resulting construct, CFP-Rem265-C1PKC, is cytosolic but can
be rapidly recruited to the plasma membrane with the phorbol
ester, PdBu (Fig. 2C). In a1C+b2a channels, membrane recruit-
ment of Rem265-C1PKC results in an attendant rapid and
substantive 60% decrease in ICa (Fig. 2D), which is solely due to
a decrease in Po [16,20]. In sharp contrast, a1C+b2aTM channels
were unaffected by membrane-recruitment of Rem265-C1PKC
(Fig. 2E). The slight 10% reduction in ICa observed in this group is
commensurate with the normal amount of channel rundown
observed in these time course experiments. These results establish
that this Rem-induced reduced-Po mechanism of channel inhibi-
tion is also mediated through the Rem/b interaction.
A third characteristic functional impact of Rem on CaV1.2
channels is a reduction of Qmax that occurs even when the decrease
in N is accounted for, and is likely accomplished by a Rem-induced
partial immobilization of a1C voltage sensors [16]. Wild-type
a1C+b2a channels yield large ON gating currents and Qmax, which
are almost eliminated in the presence of CFP-Rem (Fig. 2F).
Qualitatively similar results were obtained with mutant
a1C+b2aTM channels, which displayed a large Qmax that was
significantly reduced by CFP-Rem (Fig. 2G). Therefore, unlike the
effects on N and Po, binding to b is not necessary for Rem-induced
decrease of CaV1.2 Qmax.
Identification of a novel Rem binding region on the pore-
forming a1C subunit
The most parsimonious explanation for the existence of a b-
binding-independent mode of Rem-induced block of ICa,L is that
Rem directly binds a1C to initiate this form of CaV1.2 inhibition.
However, to date, no such functional Rem binding site on a1C has
been described. Given that Rem is localized to the intracellular
side of the plasma membrane, we hypothesized the existence of a
Rem binding site somewhere within the major cytoplasmic regions
(N-terminus, I–II loop, II–III loop, III–IV loop, and C-terminus)
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complementary methods. First, we used fluorescence resonance
energy transfer (FRET) to probe for an interaction between YFP-
Rem and CFP-tagged intracellular domains of a1C (Fig. 3B). Using
a three-cube FRET method [27,28], we found that only CFP-
tagged a1C N-terminus (CFP-a1CNT) yielded an appreciable
FRET signal when co-expressed with YFP-Rem (Fig. 3B). None of
the other CFP-tagged a1C intracellular loops yielded a FRET
signal significantly above control cells expressing YFP-Rem+CFP
(Fig. 3B, dotted line). The FRET results were not due to
differences in the stoichiometry of donor to acceptor molecules
since the estimated ratio of donor (ND) to acceptor (NA) molecules
[27,28] was similar among the different groups (Fig. S3). The
FRET results aligned with visual evidence of protein co-
localization (Fig. 3). When expressed individually, YFP-Rem is
enriched at the plasma membrane whereas CFP-a1CNT has a
mostly diffuse fluorescence through the cytosol and in the nucleus
(Fig. S4). However, when co-expressed with YFP-Rem, a fraction
of the CFP-a1CNT present in cells was targeted to the plasma
membrane, tracking the membrane localization of Rem and
providing visual evidence of an interaction (Fig. 3B; Fig. S4).
As a complementary approach, we used co-immunoprecipita-
tion (co-IP) assays to determine interaction between YFP-Rem and
individual CFP-tagged a1C intracellular domains co-transfected
into HEK 293 cells (Fig. 3C). All CFP-tagged a1C intracellular
domains and YFP-Rem were well expressed (Fig. 3C, input). Only
CFP-a1CNT co-IPed with YFP-Rem (Fig. 3C), corroborating the
results from FRET and protein co-localization approaches
(Fig. 3B). As a further control experiment, we observed no pull
down of CFP-a1CNT with anti-Rem antibody in cells transfected
with CFP-a1CNT alone (i.e., no YFP-Rem co-expressed; not
shown). We were surprised to find no binding between Rem and
a1C C-terminus (a1CCT) given a recent report that these two
proteins interact [29]. The reasons for this disparity are unclear.
However, the fact that using three independent approaches
(FRET, co-localization analyses, and co-IP) we could observe no
interaction between Rem and a1CCT while detecting association
with a1CNT effectively rules out the potential trivial explanation of
a false negative result that could conceivably be obtained with any
one method. One possibility is that the presence of fluorescent
protein tags on Rem and a1CCT may occlude or weaken this
interaction to a point where it is undetectable in our different assay
conditions.
a1CNT is comprised of 153 amino acid residues. Peptide
mapping (Fig. 3D) combined with co-IP (Fig. 3E) and confocal co-
localization (Fig. S5) experiments suggested the Rem binding site
resides in a region towards the distal end of a1CNT. This region is
immediately upstream of transmembrane segment 1 in domain I
(IS1), and shows homology (60% identical residues or conservative
substitutions) among distinct CaV1/CaV2 a1-subunit isoforms
(Fig. 3F). Surprisingly, despite the high sequence homology, Rem
did not bind CaV2.2 N-terminus (a1BNT) as determined either by
FRET (Fig. 4A) or visual inspection of protein co-localization (not
shown).
Rem association with a1CNT mediates b-binding-
independent inhibition of CaV1.2
Does Rem binding to a1CNT mediate b-binding-independent
CaV1.2 inhibition? We addressed this question in several ways.
First, given that CaV2.2 a1BNT does not bind Rem (nor do any of
the other a1B intracellular domains) (Fig. 4A), we hypothesized
that CaV2.2 would lack a b-binding-independent form of channel
inhibition. Indeed, while Rem strongly suppressed ICa in control
cells expressing a1B+b2a (Fig. 4B), it had no impact on a1B+b2aTM
channels (Fig. 4C). Hence, Rem inhibits CaV2.2 channels solely
through a b-binding-dependent mechanism. We attempted to
exchange N-termini between CaV1.2 a1C and CaV2.2 a1B,t o
determine if a1CNT is necessary and sufficient to reconstitute b-
binding-independent Rem inhibition in CaV1/CaV2 channel a1
subunits. Unfortunately, the chimeric channels gave rise to very
small currents suggesting that a1-subunit N-termini may have a
customized, non-transferable role in the structural and/or
functional maturation of individual CaV1/CaV2 channels.
As an alternative approach towards evaluating the functional
importance of Rem/a1CNT association, we determined the impact
of over-expressing a1CNT on Rem inhibition of a1C+b2a and
a1C+b2aTM channels, respectively. We reasoned that if Rem/
Figure 1. Rem inhibits CaV1.2 channels using both b-binding-dependent and independent mechanisms. (A) Alternative models for Rem
functional interaction with CaV1.2 channel complex. (B) Exemplar Ba
2+ currents from HEK 293 cells expressing wild-type CaV1.2 (a1C+b2a) in the
absence (left) or presence (right) of Rem. (C) Population current density (Ipeak) vs. voltage relationships for wild-type CaV1.2 channels in the absence
(&, n=6 for each point) or presence (red m, n=5 for each point) of Rem. Data are means 6 S.E.M. (D, E) Data for mutant CaV1.2 channels (a1C+b2aTM)
in the absence (&, n=8 for each point) or presence (red m, n=10 for each point) of Rem. Same format as B, C. In E, data from wild-type CaV1.2
channels are reproduced (dotted lines) to facilitate direct visual comparison.
doi:10.1371/journal.pone.0037079.g001
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a1CNT would, via competition, partially rescue Rem inhibition of
a1C+b2a channels, while fully overcoming Rem inhibition of
a1C+b2aTM channels (Fig. 4D). Indeed, these predictions were
borne out in functional experiments. Over-expressing a1CNT
partially relieved Rem inhibition of wild type CaV1.2 channels
(Fig. 4E; Ipeak,0mV=20.965.4 pA/pF, n=6 for cells expressing
a1C+b2a+Rem+a1CNT compared to Ipeak,0mV=2.861.2 pA/pF,
Figure 2. Distinct mechanisms of Rem inhibition of CaV1.2 differentially depend on Rem/b interaction. (A, B) Differential impact of CFP-
Rem on surface density of wild-type (a1C[BBS]-YFP+b2a) and mutant (a1C[BBS]-YFP+b2aTM)C a V1.2 channels, respectively, using a surface channel
quantum dot labeling method. Confocal images for corresponding imaging channels were obtained with identical instrument settings. Scale bar,
25 mm. (C) Rapid recruitment of CFP-Rem265-C1PKC to the plasma membrane induced by 1 mM PdBu. Scale bar, 8 mm. (D, E) PdBu-induced membrane
translocation of CFP-Rem265-C1PKC concomitantly inhibits wild-type (a1C+b2a), but not mutant (a1C+b2aTM)C a V1.2 channels. (F, G) Rem inhibits gating
currents and Qmax in both wild-type and mutant CaV1.2 channels. * P,0.05 when compared to the corresponding without Rem data using Student’s
two-tailed unpaired t test.
doi:10.1371/journal.pone.0037079.g002
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rescuing mutant channel currents (Fig. 4E; Ipeak,0mV=
80.1623.5 pA/pF, n=8 for cells expressing a1C+b2aTM+Re-
m+a1CNT compared to Ipeak,0 mV=92.4615.5 pA/pF, n=8 for
cells a1C+b2aTM). As a control experiment, a1BNT had no impact
on Rem inhibition of mutant channels (Fig. 4E; Ipeak,0 mV=
18.264.6 pA/pF, n=5 for cells expressing a1C+b2aTM+Re-
m+a1BNT compared to Ipeak,0 mV=22.265.3 pA/pF, n=10 for
a1C+b2aTM+Rem). These results are consistent with the idea that
Rem/a1CNT association mediates b-binding-independent Rem
inhibition of CaV1.2 channels.
Distinct RGK GTPases differentially use a1- and b-binding
dependent mechanisms to inhibit CaV1.2 channels
We next examined whether the use of both a1- and b-binding
mechanisms to inhibit CaV1.2 channels is a conserved feature
among the four distinct RGK GTPases. Initial indications of
fundamental differences were immediately apparent from visual
confocal co-localization images and co-immunoprecipitation
experiments which demonstrated that unlike Rem, none of the
other RGK proteins— Gem, Rem2, and Rad— bound a1CNT
(Fig. S6). We assessed the impact of individual RGKs on either
a1C+b2a or a1C+b2aTM channels reconstituted in HEK 293 cells,
and observed a sharp dichotomy in functional responses (Fig. 5A).
Whereas, all RGKs markedly inhibited ICa,L through wild-type
a1C+b2a channels only Rem and Rad also inhibited a1C+b2aTM
channels. Mutant a1C+b2aTM channels were completely refractory
to Gem and Rem2, explicitly demonstrating that these RGK
proteins utilize only b-binding-dependent mechanisms to inhibit
ICa,L (Fig. 5 A and B). The finding that Rad displayed both a b-
binding-dependent and a b-binding-independent mode of inhibi-
tion (albeit to a lesser extent than observed for Rem) was surprising
given its apparent lack of binding to a1C N-terminus (Fig. S6). We
speculated that Rad may bind to another intracellular domain of
a1C to initiate b-binding-independent inhibition of CaV1.2.
However, we could not detect any evidence of Rad binding to
any of the other major intracellular domains of a1C (Fig. S7). One
possibility is that Rad may bind to a1C using multiple weak
interactions rather than a dominant strong binding site as we have
found for Rem.
Discussion
Amongst the myriad forms of physiological modulation of CaV
channels by intracellular signaling molecules, inhibition of CaV1/
CaV2 channels by RGKs stands out for its potency (often virtual
elimination of ICa) and indiscrimination (affects all CaV1/CaV2
isoforms). In this regard, RGKs behave as polar opposites to CaV
channel auxiliary b subunits which interact promiscuously with all
CaV1/CaV2 to stimulate ICa by increasing channel membrane
trafficking and increasing single-channel open probability (Po).
Given this fact, the discovery that RGKs bind bs led to the widely-
held assumption that RGK/b interaction was fundamental to the
mechanism of channel inhibition [15,30]. Early renditions of this
idea suggested that RGKs bound to bs and prevented their
interaction with a1 subunits, thereby compromising channel
trafficking to the membrane [10,31,32], and leaving channels at
the cell surface in a low-Po ‘a1-alone’ mode [33]. However, it was
subsequently shown that RGKs do not disrupt the a1-b interaction
leading to revised models invoking a ternary a1/b/RGK complex
in which bs bridge a1 subunits and RGKs to initiate ICa inhibition
[11,16,20,34,35]. Recently, the primacy of the RGK/b interaction
in the mechanism of ICa inhibition has been challenged based on
the interesting finding that preventing Gem interaction with b did
Figure 3. Rem binds a1C N-terminus. (A) Schematic of a1C showing
four homologous transmembrane domains (I–IV), intracellular N/C
termini and domain-connecting loops. (B) Top, interaction of individual
CFP-tagged a1C intracellular loops and termini with YFP-Rem probed
using FRET. Dotted line represents YFP-Rem+CFP (n=10). Bottom,
confocal images. Scale bar, 8 mm. (C) CFP-tagged a1CNT co-immuno-
precipitates with YFP-Rem. All the co-ip lanes and the first input lane
were from the same gel. The rest of the input lanes were from a second
gel run simultaneously because there were insufficient lanes available in
the first gel to accommodate all samples, including marker lanes.
Hence, in the input gel image (right) the first lane (CFP-NT) was spliced
onto the rest of the lanes (dotted line). The co-ip gels have been
cropped to remove light chain IgG bands from the precipitating
antibody. (D) Schematic of a1CNT peptide fragments. (E) Co-immuno-
precipitation of YFP-tagged a1CNT peptide fragments with CFP-Rem. (F)
Sequence comparison of last 22 N-terminus residues among distinct
CaV1/CaV2 channel a1 subunits.
doi:10.1371/journal.pone.0037079.g003
RGKs Use Distinct Mechanisms to Block CaV Channels
PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37079not impair its ability to block CaV2.1 (P/Q) channels [21]. In the
wake of this report, it is unclear whether the RGK/b interaction
has any role in the mechanism of ICa inhibition, or merely
represents an unrelated epiphenomenon. We have investigated
this issue using a b2a-subunit mutant that selectively loses binding
to RGK proteins. The new findings presented in this work are: (1)
Rem inhibits CaV1.2 channels using both b-binding-dependent
and b-binding–independent mechanisms; (2) binding to b is
required for Rem-mediated decrease in CaV1.2 channel surface
density (N) and open probability (Po), but not Qmax; (3) Rem
associates with a1C N-terminus to initiate b-binding-independent
inhibition; (4) Rem inhibits CaV2.2 channels using a solely b-
binding-dependent mechanism; (5) distinct RGKs differentially use
b-binding-dependent and a1-binding-dependent mechanisms to
inhibit CaV1/CaV2 channels.
The finding that all four RGKs use (at least partially) b-binding-
dependent mechanisms to suppress CaV1.2 channels, reasserts the
importance of the RGK/b interaction for ICa inhibition. Indeed,
for Gem and Rem2, a b-binding-dependent mechanism was the
sole mode for inhibiting CaV1.2 channels. Similarly, Rem
inhibited CaV2.2 channels solely through a b-binding-dependent
Figure 5. Distinct RGKs differentially use b-binding-dependent
and independent mechanisms to inhibit CaV1.2 channels. (A)
Histogram showing impact of individual RGKs on wild-type (a1C+b2a)
and mutant (a1C+b2aTM)C a V1.2 channels. *, #, $ P,0.05 when
compared to a1C+b2a, a1C+b2aTM,o ra1C+b2a+RGK, respectively, using
two-tailed unpaired Student’s t test. (B) Cartoon showing dichotomy in
the determinants used by distinct RGKs to inhibit CaV1.2 channels.
doi:10.1371/journal.pone.0037079.g005
Figure 4. Rem interaction with a1C N-terminus mediates b-
binding-independent inhibition. (A) Top, topography of CaV2.2 a1B
subunit. Bottom, interaction of CaV2.2 a1B intracellular domains with
YFP-Rem probed using FRET. Dotted lines represent FRET data from
YFP-Rem+CFP-a1CNT and YFP-Rem+CFP, respectively. (B, C) Population
Ipeak-V relationships for wild type (a1B+b2a) and mutant (a1B+b2aTM)
CaV2.2 channels, respectively, in the absence (&, n=5 for wild type
channels, and n=9 for mutant channels) or presence (red m, n=5 for
wild type channels, and n=10 for mutant channels) of Rem. Data are
means 6 S.E.M. (D) Schematic showing rationale and predictions for a1C
N-terminus over-expression experiments. (E) Histogram showing impact
of a1C or a1B N-terminus on wild-type (a1C+b2a) and mutant (a1C+b2aTM)
CaV1.2 channels in the presence of Rem. * P,0.05 when compared to
a1C+b2a or a1C+b2aTM using two-tailed unpaired Student’s t test. #
P,0.05 when compared to a1C+b2a+Rem or a1C+b2aTM+Rem using two-
tailed unpaired Student’s t test.
doi:10.1371/journal.pone.0037079.g004
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CaV1.2 channels. Beyond b-binding-dependent inhibition, Rem
and Rad also blocked CaV1.2 channels in a b-binding-indepen-
dent manner. For Rem, this response was mediated through an
association with a1CNT. The discovery of an a1C-binding-
dependent mode of RGK inhibition in CaV1.2 channels aligns
with the finding that Gem inhibits CaV2.1 channels in a b-
binding-independent (and presumably a1A-binding-dependent)
manner [21]. Taken together with previous studies [21,22], our
data suggests a dualistic view for RGK regulation of CaV1.2
channels. First, all RGKs can inhibit CaV1/CaV2 channels by
interacting with b subunits. The essential role of bs in the
functional maturation of all CaV1/CaV2 channels may, therefore,
explain the indiscriminate nature of RGK inhibition of ICa
through HVA CaV channels. Second, distinct RGKs can
selectively inhibit specific CaV1/CaV2 channel isoforms by
differentially binding to individual a1 subunits. This insight may
be potentially exploited to engineer RGKs with sole selectivity for
individual a1 subunits as a means of creating custom, isoform-
specific genetically encoded CaV1/CaV2 channel inhibitors [17].
For Rem inhibition of CaV1.2, the a1C-binding-dependent and b-
binding-dependent mechanisms appear to be equally potent in
blocking ICa,L.
How does binding of RGK proteins to either b or a1 subunits
actually suppress ICa? Rem inhibition of recombinant CaV1.2
channels occurs via multiple mechanisms including: decreased N
(due to enhanced dynamin-dependent endocytosis), Po, and Qmax
(due to voltage sensor immobilization) [16]. Interestingly, Rem-
induced decrease in N and Po (but not Qmax) was b-binding-
dependent. Understanding precisely how the Rem/b interaction
leads to channel endocytosis and decreased Po is an interesting
question for future experiments. It is tempting to speculate that
Rem-induced reduction in Qmax (voltage sensor immobilization)
underlies a1C-binding-dependent inhibition of CaV1.2. Neverthe-
less, we cannot rule out that Rem binding to a1CNT may also
inhibit channel Po using a parallel mechanism that is independent
of voltage sensor immobilization. Such mechanistic details may
potentially be resolved by evaluating the structural determinants
on Rem necessary for a1C-binding-dependent inhibition [16].
Over the last decade, several groups have investigated
mechanisms of RGK GTPase inhibition of CaV channels,
sometimes with discrepant results [10,11,12,16,21,31,35,36,37].
Often, across the various groups, these studies have involved
different RGKs and distinct CaV1/CaV2 channel types, as well as
varied experimental systems. This work produces the new insight
that the mode of RGK-mediated CaV channel inhibition is
customized at both the channel and GTPase level. Hence, a
particular RGK can employ divergent mechanisms to block
distinct CaV channel types, while a specific CaV channel isoform
can be inhibited by different RGKs with diverse mechanisms. This
perspective may help explain some of the inconsistent results
previously published regarding RGK regulation of CaV channels.
In conclusion, this work contributes to the growing realization
that the seemingly simple phenomenon of RGK inhibition of
CaV1/CaV2 channels is underlain by a rich variety of mechanisms
and structural determinants [16,36]. Such mechanistic complexity
may be physiologically relevant as it could significantly enrich the
functional versatility of RGKs as Ca
2+ channel blockers in
excitable cells. For example, RGK inhibition of ICa could occur
on different timescales depending on the mode of block of CaV
channels– b-binding-dependent decreases in N could lead to long-
term reductions in current, while b-binding-independent regula-
tion of Qmax produces short-term tuning of ICa. In-depth
understanding of the complexities underlying RGK regulation of
ICa will be important for deciphering such physiological dimen-
sions of this channel modulation, and may be potentially exploited




XFP-tagged RGK constructs [mouse Rem (NM_009047);
human Gem (NM_181702); human Rem2 (NM_173527); mouse
Rad (NM_019662)] were generated by first polymerase chain
reaction (PCR) amplifying and cloning XFP into pcDNA4.1
(Invitrogen) using KpnI and BamHI sites. Subsequently, RGK
constructs were PCR amplified and cloned downstream of XFP
using BamHI and EcoRI sites. To generate CFP-Rem265-C1PKCc,
we used overlap extension PCR to fuse residues 26–89 of mouse
PKCc [38] to the C terminus of Rem265. The fusion product was
subsequently cloned downstream of CFP using BamHI and EcoRI
sites. CFP-a1C intracellular loops constructs were amplified by
PCR and cloned downstream of the XFP molecule using BamHI
and EcoRI sites. To generate XFP-tagged CaVb constructs, we
PCR amplified and cloned XFP into pAd CMV using BamHI and
XbaI sites. CaVbs were amplified by PCR and cloned upstream of
the XFP molecule using NheI and BamHI sites. Point mutations in
b were generated using QuikChange Site-Directed Mutagenesis
Kit (Stratagene). The thirteen-residue bungarotoxin binding site
[BBS] [39] was engineered into the domain II S5–S6 extracellular
loop of a1C at residue 713 using unique restriction enzyme sites,
StuI and BbrPI. Primers that extended from the unique restriction
sites were used together with primers containing the BBS sequence
in an overlap extension PCR reaction. The overlap extension
product was directly ligated into a1C-YFP to generate a1C[BBS]-
YFP.
All PCR products were verified by sequencing
Cell culture and transfection. Low-passage-number HEK
293 cells (gift from Dr. Robert Kass, Columbia University) [40]
were maintained in DMEM supplemented with 10% FBS and
100 mgm l
21 penicillin-streptomycin. HEK 293 cells cultured in 6-
cm tissue culture dishes were transiently transfected with
CaV1.2a1C (6 mg), b2a (6 mg), T antigen (2 mg), and the appropri-
ate RGK construct (4 mg), using the calcium phosphate precipi-
tation method. Cells were washed with PBS 5–8 h after
transfection and maintained in supplemented DMEM. For
confocal microscopy experiments, transfected HEK 293 cells were
replated onto fibronectin-coated culture dishes with No. 0 glass
coverslip bottoms (MaTek). For electrophysiology experiments
cells were replated onto fibronectin-coated glass coverslips 24 h
after transfection.
Electrophysiology
Whole-cell recordings were conducted 48–72 h after transfec-
tion using an EPC-8 or EPC-10 patch clamp amplifier (HEKA
Electronics) controlled by PULSE software (HEKA). Micropi-
pettes were fashioned from 1.5-mm thin-walled glass with filament
(WPI Instruments), and filled with internal solution containing (in
mM): 135 cesium methanesulphonate (MeSO3), 5 CsCl, 5 EGTA,
1 MgCl2, 4 MgATP (added fresh) and 10 HEPES (pH 7.3). Series
resistance was typically 1.5–2 MV. There was no electronic series
resistance compensation. External solution contained (in mM): 140
tetraethylammonium-MeSO3, 5 BaCl2, and 10 HEPES (pH 7.3).
Whole-cell I–V curves were generated from a family of step
depolarizations (240 to +100 mV from a holding potential of
290 mV). Currents were sampled at 25 kHz and filtered at 5 or
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and capacitive currents were subtracted using a P/8 protocol.
Labeling of cell surface CaV1.2 channels with QD655
Transfected cells were washed twice with PBS containing
calcium and magnesium (pH 7.4, 0.9 mM CaCl2 and 0.49 mM
MgCl2), and incubated with 1 mM biotinylated a-bungarotoxin in
DMEM/3% BSA in the dark for 1 h at room temperature. Cells
were washed twice with DMEM/3% BSA, and incubated with
10 nM streptavidin-conjugated QD655 for 1 h at 4uC in the dark.
For confocal microscopy, cells were washed with PBS, and imaged
in the same buffer. For flow cytometry, cells were harvested with
trypsin, washed with PBS and assayed in the same buffer.
Confocal microscopy
Static images of a1C[BBS]-YFP, XFP-Rem constructs and
quantum dots signal were observed using a Leica TCS SPL AOBS
MP Confocal microscope system and a 406 oil objective (HCX
PL APO 1.25-.75 NA). HEK 293 cells expressing CFP/YFP fusion
proteins were imaged using a 458/514-nm Argon laser line for
excitation and red signals were imaged using a 633-nm helium-
neon laser line for excitation.
Flow cytometry
Cells were counted using a BD LSRII Cell Analyzer. HEK 293
cells expressing CFP/YFP fusion proteins were excited at 407 and
488-nm, respectively, and red signal was excited at 633-nm. For
each group of experiments we used isochronal untransfected and
single color controls to manually set the appropriate gain settings
for each fluorophore to ensure signals remained in the linear range
and to set threshold values. The same gain settings were then used
for assaying all isochronal transfection samples. Flow cytometry
data were analyzed using FlowJo software.
Immunoprecipitation and immunoblotting
Confluent cultures of HEK 293 cells plated in 6-cm tissue
culture dishes were harvested 48 h after transfection. Cells were
washed in PBS and resuspended in 0.5 mL cold lysis buffer
(50 mmol/L Tris-HCl, 150 mmol/L NaCl, 1% NP-40) containing
16 protease inhibitor cocktail for 30 minutes. Cell lysates were
centrifuged at 10,0006g for 15 minutes at 4uC, and the
supernatant precleared by incubation with 50 mL protein G beads
slurry for 1 h. The mixture was centrifuged and the resulting
supernatant incubated with 4 mg primary antibody [Santa Cruz
Biotechnology: anti-Rem (SC58472); anti-Gem (SC19753); anti-
Rem2 (SC160720); anti-Rad (SC49714)] and 50 mL protein G
slurry for 1 h on a rotator. The mixture was again centrifuged, and
the pellet washed four times with lysis buffer. 50 mL Laemmli
sample buffer was added to the bead pellet and the mixture
vortexed and heated (90u–100uC for 10 minutes). The sample was
centrifuged and the supernatant loaded onto a gel for subsequent
SDS-PAGE and Western blot analyses. For immunoblots, primary
antibodies to GFP (Invitrogen, A6455) were detected by horse-
radish peroxidase-conjugated secondary antibodies (goat-anti
rabbit obtained from Thermo Scientific, 32260) and enhanced
chemiluminescence.
Fluorescence resonance energy transfer (FRET)
Determination of RGK-a1 subunit intracellular domain inter-
actions in live cells was accomplished using the three-cube FRET
algorithm as previously described [27,28]. Cells transfected with
XFP-tagged proteins were washed with Tyrode’s solution and
placed on an inverted microscope equipped for epifluorescence.
Individual cells were excited using a 150-W Xenon arc lamp light
source, and epifluorescence emission signals measured with a
photomultiplier tube were integrated by a fluorometer and
digitized. For each cell, three successive measurements were taken
with filter cube sets optimum for measuring CFP, YFP, and FRET
signals, respectively. Background and autofluorescence levels were
determined by averages from single untransfected cells, and
subtracted from experimental values from each cube. The FRET
ratio (FR) was calculated from background-corrected experimental
measurements as previously described [27,28].
Data and statistical analyses
Data were analyzed off-line using PulseFit (HEKA), Microsoft
Excel and Origin software. Statistical analyses were performed in
Origin using built-in functions. Statistically significant differences
between means (P,0.05) were determined using two-tailed
unpaired Student’s t test. Data are presented as means 6 S.E.M.
Supporting Information
Figure S1 Evidence that bTM loses binding to Rem. (A)
Confocal images of a HEK 293 cell co-expressing CFP-Rem265-
C1PKC and wild type YFP-b3. Under basal conditions both CFP
and YFP fluorescence are diffusely distributed in the cytosol. Upon
addition of 1 mM PdBu (5 min), CFP-Rem265-C1PKC is recruited
to the nuclear and plasma membrane. The sub-cellular localiza-
tion of YFP-b3 dynamically follows that of CFP-Rem265-C1PKC,
providing visual evidence of an interaction between the two
proteins. Scale bar, 5 mm. (B) A mutant b3 featuring three point
mutations, YFP-bTM, does not bind CFP-Rem265-C1PKC,a s
reported by the dynamic sub-cellular co-localization assay. (C) Co-
immunoprecipitation assay indicates YFP-b2a associates with CFP-
Rem, and that this interaction is lost with YFP-b2aTM.
(TIF)
Figure S2 Exemplar raw data from flow cytometry
experiments used to determine the relative surface
density of CaV1.2 channels. (A) Confocal images showing
quantum dot labeling of cells transfected with a1C[BBS]-YFP+b2a
6 CFP-Rem (left) and a1C[BBS]-YFP+b2aTM 6 CFP-Rem (right).
Images are reproduced from Fig. 2A, B. Scale bar, 25 mm. (B)
Raw data from isochronal flow cytometry experiments showing
fluorescence intensity of QD655 versus YFP signals for cells
expressing a1C[BBS]-YFP+b2a+CFP-Rem (left) and a1C[BBS]-
YFP+b2aTM+CFP-Rem (right). 50,000 cells were counted for each
condition. Vertical and horizontal lines are threshold values set
based on isochronal experiments using untransfected and single
color control cells. Each dot represents a single cell. Dots have
been arbitrarily color coded to facilitate visualization of distinct
populations. Loosely, green dots represent a1C[BBS]-YFP-positive
cells that lack appreciable trafficking to the membrane (low QD655
signal), while red dots represent a1C[BBS]-YFP-positive cells that
display robust CaV1.2 channel trafficking to the surface (high
QD655 signal). Black dots in the bottom left quadrant correspond
to untransfected cells.
(TIF)
Figure S3 Histogram showing estimates of donor:ac-
ceptor ratio (ND/NA) for FRET experiments shown in
Fig. 3.
(TIF)
Figure S4 Visual evidence that Rem selectively binds
a1C N-terminus. (A) Representative confocal images showing
sub-cellular localization of YFP-tagged a1C intracellular domains
when expressed alone in HEK 293 cells. Aside from I–II loop,
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other a1C intracellular domains show mostly diffuse distribution
throughout the cell. Scale bar, 5 mm. (B) Top row, representative
images of YFP-Rem demonstrate that this protein is membrane
enriched when expressed in HEK 293 cells. Bottom row,
representative images showing sub-cellular localization of CFP-
tagged a1C intracellular loops co-expressed with YFP-Rem. Only
CFP-a1CNT demonstrated redistribution from the cytosol to the
plasma membrane when co-expressed with YFP-Rem. (C) Line
scan analyses of CFP fluorescence from cells co-expressing YFP-
Rem and CFP-tagged a1C intracellular loops. Membrane
localization of CFP-a1CNT and CFP-a1CI–II is evident from the
sharp twin peaks of fluorescent signal separated by (cytoplasmic)
regions with lower fluorescence intensity. Line scans were drawn
to avoid the nucleus and areas with clustered fluorescence. (D)
Relative membrane to cytosol fluorescence intensity ratios for
CFP-tagged a1C intracellular domains either expressed alone or
together with YFP-Rem in HEK 293 cells. Absence of membrane
targeting results in a ratio of one, while membrane localization/
enrichment of a protein yields a ratio greater than one. By this
analysis, only CFP-a1CNT showed an increase in membrane
localization when co-expressed with YFP-Rem. CFP-a1CI–II
showed a relative decrement in membrane localization when co-
expressed with YFP-Rem, perhaps reflecting a competition for
membrane binding sites.
(TIF)
Figure S5 Mapping the Rem binding site in a1C N-
terminus. (A) Schematic of a1CNT peptide fragments used to
map Rem binding site. (B) Co-localization pattern of specific YFP-
tagged a1C N-terminus fragments with CFP-Rem at the plasma
membrane suggests Rem binds the distal end of a1C N-terminus.
Scale bar, 5 mm. (C) Relative membrane to cytosol fluorescence
intensity ratios for YFP-tagged a1CNT fragments co-expressed
with CFP-Rem. Ratios greater than unity indicate membrane
targeting/enrichment of fluorescence signal. Line scan analyses
avoided the nucleus and clustered fluorescence signals from
cytosolic areas.
(TIF)
Figure S6 Lack of interaction of Gem, Rem2, and Rad
with a1C N-terminus. (A) Confocal images of YFP-a1CNT with
CFP-tagged Gem, Rem2, and Rad show little co-localization.
Scale bar, 5 mm. (B) Relative membrane to cytosol fluorescence
intensity ratios for YFP-a1CNT co-expressed with distinct CFP-
tagged RGK proteins. (C) Co-immuoprecipitation assay to probe
for a1CNT interaction with Gem, Rem2, or Rad provides no
evidence of an association.
(TIF)
Figure S7 Lack of interaction of Rad with a1C intracel-
lular loops. (A) Confocal images of mCherry-Rad and CFP-
tagged a1C intracellular loops and termini show no evidence of co-
localization. Scale bar, 5 mm. (B) Relative membrane to cytosol
fluorescence intensity ratios for YFP-tagged a1C intracellular loops
co-expressed with distinct mCherry-tagged Rad. (C) Co-immuno-
precipitation assays indicate no interaction between Rad and the
major a1C intracellular loops.
(TIF)
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